Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDevelop North Regulatory News (DVNO)

Share Price Information for Develop North (DVNO)

Share Price is delayed by 15 minutes
Get Live Data
76.50    0.00 (0.00%)
Bid:
73.00
Ask:
80.00
Spread: 7.00 (9.589%)
Market Cap: £19.91m
DVNO Live PriceLast checked at - London Stock Exchange

Intraday Develop North Share Chart

Replacement: Commencement of Share Buyback Program

20 Nov 2023 07:00

RNS Number : 9014T
Develop North PLC
20 November 2023
 

REPLACEMENT: This announcement replaces that published at 07:00 on 13 November 2023 with RNS reference 1563T. The final paragraph of the original announcement has been amended to reflect that, due to the limited liquidity in the shares, the Company will not benefit from the exemption contained in Article 5(1) of Regulation (EU) No. 596/2014 as adopted into UK law by the European Union (Withdrawal) Act 2018. The commencement date of the share buyback programme has also been changed from 13 November 2023 to 20 November 2023. All other aspects of the announcement are unchanged from that published on 13 November 2023.

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR THE UNITED STATES OF AMERICA OR TO US PERSONS, OR TO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

For release on 20 November 2023

 

DEVELOP NORTH PLC

(the "Company")

 

Commencement of Share Buyback Programme

 

The Board of Develop North PLC today announces the commencement of a share buyback programme (the 'programme') whereby the Company will repurchase its Ordinary Shares (the 'shares') for up to a maximum consideration of £500k. All shares purchased under this programme will be held in treasury.

 The Company has entered into a non-discretionary agreement with Cavendish Capital Markets Limited, acting as principal to conduct the programme and to repurchase shares on the Company's behalf and to make trading decisions under the programme independently of the Company in accordance with agreed parameters.

 The programme will commence today, 20 November 2023, and will end on 31 December 2023. The programme is subject to customary early termination rights.

The programme will at all times be conducted in accordance with (and within the parameters prescribed by the Company's general authority to repurchase shares (which authorised the repurchase of a maximum of 4,035,917 shares, being approximately 14.99% of the Company's issued share capital) as approved by shareholders at the Company's AGM on 27 April 2023.

Due to the limited liquidity in the shares, a buyback of shares pursuant to the above authority on any given trading day may represent all or a significant proportion of the daily trading volume in the shares and could exceed 25% of the average daily trading volume and, accordingly, the Company will not benefit from the exemption contained in Article 5(1) of Regulation (EU) No. 596/2014 as adopted into UK law by the European Union (Withdrawal) Act 2018.

 

 

For further information regarding Develop North PLC (LEI: 213800EXPWANYN3NEV68) please contact: 

 

Develop North PLC

Ian McElroy 

+44 (0) 191 222 0099

Tier One Capital Ltd (Investment Adviser)

Brendan O'Grady

+44 (0) 191 222 0099

Apex Fund Administration Services (UK) Limited (Secretary)

Nicola Board 

+44 (0) 1245 398950

Cavendish Capital Markets Limited (Sponsor, Broker and Financial Adviser)

William Marle

+44 (0) 207 220 0500

 

Develop North PLC PLC is a closed-end investment company listed on the main market of the London Stock Exchange and specialises in providing finance to the residential and commercial property sector.

 The Company's investment adviser is Newcastle upon Tyne based Tier One Capital Limited. Tier One Capital is a wealth management and property lending firm providing financial advice services and bespoke tailored lending to the property development market.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZMMMVRNGFZM
12
Date   Source Headline
5th May 20261:58 pmRNSTotal Voting Rights
30th Apr 20261:41 pmRNSResult of Annual General Meeting
30th Apr 20261:38 pmRNSNet Asset Value(s)
14th Apr 202612:02 pmRNSChange of Venue for Annual General Meeting
31st Mar 20263:33 pmRNSResult of Equity Issue
24th Mar 20262:45 pmRNSChange of Registered Office
24th Mar 202612:17 pmRNSPublication of a Supplementary Prospectus
12th Mar 20266:20 pmRNSAnnual Financial Report
26th Feb 20262:14 pmRNSDividend Declaration
18th Feb 20262:18 pmRNSGeneral Meeting Result
26th Jan 20267:00 amRNSAppointment of Chief Executive Officer
20th Jan 20262:30 pmRNSChange of Registered Office
16th Jan 202611:12 amRNSRetail Offer
16th Jan 202611:11 amRNSPublication of a Prospectus
14th Jan 20267:00 amRNSNet Asset Value(s)
8th Dec 20259:33 amRNSDividend Declaration
10th Nov 20252:59 pmRNSNet Asset Value(s)
17th Oct 20253:31 pmRNSNon-material change to investment policy
29th Aug 20259:32 amRNSDividend Declaration
11th Aug 20257:00 amRNSHalf-year Report
9th Jul 20257:00 amRNSChange to Investment Policy & Potential Fundraise
4th Jun 20255:52 pmRNSDividend Declaration
2nd May 20257:00 amRNSAppointment of Non-Executive Director
1st May 20255:46 pmRNSResult of Annual General Meeting
1st May 202512:02 pmRNSNet Asset Value(s)
19th Mar 20252:29 pmRNSAnnual Financial Report
12th Mar 20255:24 pmRNSDividend Declaration
21st Nov 20242:35 pmRNSDividend Declaration
21st Nov 20242:31 pmRNSNet Asset Value(s)
30th Aug 20247:00 amRNSDividend Declaration
31st Jul 20242:07 pmRNSNet Asset Value(s)
31st Jul 20242:05 pmRNSHalf-year Report
31st May 202412:55 pmRNSDividend Declaration
1st May 20247:00 amRNSTotal Voting Rights
26th Apr 20247:05 amRNSResult of AGM
26th Apr 20247:00 amRNSNet Asset Value(s)
15th Apr 20241:49 pmRNSTransaction in Own Shares
12th Apr 20245:22 pmRNSTransaction in Own Shares
12th Apr 20244:23 pmRNSTransaction in Own Shares
4th Apr 20249:32 amRNSCommencement of New Share Buyback Programme
26th Mar 20247:00 amRNSAnnual Financial Report
29th Feb 202412:06 pmRNSDividend Declaration
2nd Jan 20249:29 amRNSTotal Voting Rights
21st Dec 20234:55 pmRNSTransaction in Own Shares
18th Dec 20234:45 pmRNSTransaction in Own Shares
13th Dec 20235:03 pmRNSTransaction in Own Shares
8th Dec 20235:01 pmRNSTransaction in Own Shares
7th Dec 20237:00 amRNSExtension of Share Buyback Programme
1st Dec 202312:49 pmRNSTotal Voting Rights
23rd Nov 202311:22 amRNSDividend Declaration
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.